Chamber and committees

We continue to fund the Managed Alcohol Programme pilot in Glasgow being run by Simon Community Scotland. We await the evaluation of the pilot being undertaken by the University of Stirling before reaching a position on future expansion.

The MAP pilot itself does not contribute directly to work being done to address alcohol-related brain damage, as those impacted by ARBD are referred elsewhere. NHS Greater Glasgow and Clyde does offer ARBD supported accommodation through Penumbra.

The Scottish Government will encourage local delivery partners such as Health and Social Care Partnerships to identify training needs and ensure staff are able to receive all relevant training.

The need for more specific training on ARBD is now something local delivery partners should be addressing and the Scottish Government will be keen to promote this wherever possible.

We have committed to publishing a National Specification for alcohol and drug treatment and support services. The Specification will set out what services are required to implement the Charter of Rights for people affected by substance use, which includes those impacted by ARBD.

NHS GGC agreed in May 2024 that its PCANOS model and staff would be embedded into their specialist Alcohol and Drug Recovery Services in order to ensure long term sustainability. The realignment of PCANOS expertise into Glasgow Alcohol and Drug Recovery Services ensures that staff are fully supported by the wider Alcohol and Drug Recovery Service team to provide a full range of clinical, medical and psychosocial support services to individuals.

Glasgow City ADP greatly value the variety of specialist alcohol services across the city in dealing with the public health crisis in relation to alcohol. The Managed Alcohol Programme, the Fibro scanner pilot and the community and residential Alcohol Related Brain Damage Services are just some examples of the innovative and impactful provision in the city.

The Scottish Government is fully supportive of the actions being taken by both NHS GGC and Glasgow City ADP.

The Fracture Liaison Services (FLS) audit was commissioned by Scottish Government in July 2024. Whilst there was an initial delay regarding recruitment, this has now been completed, and progress now continues at pace.

Public Health Scotland are responsible for the delivery of the FLS audit and Scottish Government officials remain close to its development.

In line with all newly commissioned audits, we expect the audit to take several years to create high-quality, standardised data and consistency across NHS Boards in order to drive improvements and support clinical decision making.

I refer the member to the answer to questions S6W-35534 and S6W-35567 on 21 March 2025. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

Since 2019, the Scottish Government has been supporting the sport sector to offer free period products; reducing stigma and addressing overarching gender equality.

I refer the member to the answer to question S6W-30734 on 11 November 2024. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

In addition to the information provided in answer S6W-30734, sportscotland’s Working with Female Athletes learning platform on Brightspace has recently been updated to include additional e-learning resources. This includes Sport Wales’ e-learning module on the menstrual cycle in sport. Resources are available for all and are free of charge.

In 2024-25, we allocated over £450,000 to gynaecology from our £30 million targeted investment in planned care, delivering around 3,500 additional new outpatient appointments.

The 2025-26 Budget will provide a record £21.7 billion for Health & Social Care, including a commitment to provide £200 million to help reduce waiting times and improve capacity, and gynaecology is being targeted as a key priority area for additional funding.

Our Women’s Health Champion, Professor Anna Glasier, and I have been meeting with clinicians to better understand the challenges that currently exist within gynaecology services, to discuss innovative solutions, and to reiterate our commitment that timely access to gynaecology services is a key priority area for the Scottish Government and for the next phase of the Women’s Health Plan.

Furthermore, the Scottish Government commissioned Centre for Sustainable Delivery (CfSD) has developed a strong clinically-led Specialty Delivery Groups (SDG) for Gynaecology, which promotes multidisciplinary team working and supports local adoption of service improvement programmes. This group has supported several new and innovative pathway developments, many of which are now being successfully scaled up across Scotland, including Active Clinical Referral Triage (ACRT) and Patient Initiated Review (PIR).

The Scottish Medicines Consortium (SMC) appraises newly licensed medicines for clinical and cost-effectiveness to help Health Boards determine whether a medicine should be accepted for routine use within the NHS in Scotland. Following the appraisal process, the SMC publishes advice for Health Boards in Scotland to consider. The SMC does not issue tailored guidance for specific medicines.

The Women’s Health Plan sets out that healthcare for women should be holistic, inclusive, respectful, centred around the individual and responsive to their needs and choices.

In 2023, we carried out research on ‘Women's experiences of discrimination and the impact on health ’ so that we can better understand the lived experience of women and girls in Scotland and the discrimination they have experienced when seeking healthcare.

Through the Women’s Health Platform on NHS Inform we have created resources that can be used by women and girls and healthcare professionals to support shared decision making and a patient centred approach. This includes symptom questionnaires on menopause and menstrual health and clinical tools such as the Endometriosis Care Pathway and the Heavy Menstrual Bleeding Pathway to support informed discussions and provide better understanding of the next steps on a healthcare journey.

We have also funded the development of educational resources to support health professionals to learn more about menstrual health, endometriosis and menopause, the symptoms and treatment options.

The Scottish Government has commissioned Healthcare Improvement Scotland to develop a set of maternity standards, designed to drive improvements in care at a local level and support consistency of service design and delivery across Scotland. This process has started, and we expect the standards to be completed in late 2025.

In addition, we welcomed the announcement from Healthcare Improvement Scotland in 2024 that they would initiate inspections of maternity services as part of the Safe Care Inspection process. These inspections started in late January 2025.

Our Best Start programme described a range of measures to improve care, the vast majority of which are now in place. We continue to work closely with NHS Boards, clinical leaders, the third sector and national partners to share learning, respond to emerging evidence and identify opportunities for continuous improvement at the national level.

Through the actions in our Women’s Health Plan we have taken steps to support both women and health professionals to learn more about endometriosis, the symptoms and treatment options, so that waiting times for diagnosis can improve.

This includes the development of an Endometriosis Care Pathway for NHS Scotland; funding the development of educational resources for healthcare professionals and our Women’s Health Platform on NHS Inform which aims to provide women with the information and tools they need to make informed decisions about their health.

The Women’s Health Plan highlights the need to improve the data on women’s health. That is why we published the Women’s Health Plan Data Landscape Review in November 2024. Improving data on women’s health and on endometriosis will continue to be a priority as we develop the next phase of the Women’s Health Plan.

Information about the progress to date against each of the priorities in the Women’s Health Plan can be found in the Women’s Health Plan Final Report.